Mutations
PSEN1 V261I
Quick Links
Overview
Pathogenicity: Alzheimer's Disease : Pathogenic
Clinical Phenotype: Alzheimer's Disease
Reference Assembly: GRCh37 (105)
Position: Chr14:73664750 G>A
dbSNP ID: NA
Coding/Non-Coding: Coding
Mutation Type: Point, Missense
Codon Change: GTT to ATT
Reference Isoform: PSEN1 isoform 1 (467 aa)
Genomic Region: Exon 8
Findings
This mutation was found in an individual diagnosed with familial AD (Miravalle et al., 2005). Symptoms emerged at age 48 and death occurred at 55. The patient was homozygous for the APOE3 allele and had no mutations in exons 16 and 17 of the APP gene. Although the disease was described as familial, no information was reported for family members.
Neuropathology
Neuropathology was consistent with AD, including neuritic plaques, diffuse amyloid deposits, and cotton wool plaques. The latter were the most abundant amyloid species, with widespread distribution in the neocortex, caudate nucleus, putamen, thalamus, amygdala, hippocampus, parahippocampus, and midbrain. The predominant Aβ species in cotton wool plaques were amino-terminally truncated Aβ42 and Aβ43 peptides, with no detectable Aβ40. A similar Aβ composition was observed in the diffuse amyloid deposits of the cerebellum. In contrast, in the amyloid deposits associated with parenchymal and leptomeningeal vessels, Aβ40 was the predominant species.
Biological Effect
Unknown.
Last Updated: 23 Aug 2019
References
Paper Citations
- Miravalle L, Calero M, Takao M, Roher AE, Ghetti B, Vidal R. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry. 2005 Aug 16;44(32):10810-21. PubMed.
Further Reading
No Available Further Reading
Protein Diagram
Primary Papers
- Miravalle L, Calero M, Takao M, Roher AE, Ghetti B, Vidal R. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Biochemistry. 2005 Aug 16;44(32):10810-21. PubMed.
Other mutations at this position
Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.
Comments
Inserm
This interesting paper corroborates the new concept that N-terminal truncated Aβ42 species are the seeds of amyloidosis, and a nice target for the vaccination approach.
References:
Sergeant N, Bombois S, Ghestem A, Drobecq H, Kostanjevecki V, Missiaen C, Wattez A, David JP, Vanmechelen E, Sergheraert C, Delacourte A. Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. J Neurochem. 2003 Jun;85(6):1581-91. PubMed.
View all comments by Andre DelacourteMake a Comment
To make a comment you must login or register.